首页 / 院系成果 / 成果详情页

A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues 期刊论文

编号：

72aa8cf0-989b-4cc9-9ef4-2afdd6a108d3
作者：

Yang, JuLun#*^[1]Liu, DuXian^[2];Zhen, ShiJian^[2];Zhou, YunGang^[2];Zhang, DaiJun^[1];Yang, LiYing^[1];Chen, HaoBing^[1];Feng, Qiang^[1];
语种：

英文
期刊：

BMC CANCER ISSN：1471-2407 2016 年 16 卷 ; FEB 20
收录：
关键词：

p21Ras scFv Tumour Immunoreactivity Monoclonal antibody
摘要：

Background: The ras genes play an important role in the development and progression of human tumours. Neutralizing Ras proteins in the cytoplasm could be an effective approach to blocking ras signalling. In this study, we prepared anti-p21Ras single chain fragment variable antibody (scFv) and investigated its immunoreactivity with human tumours.
Methods: The coding sequences of H-ras, K-ras, and N-ras were separately ligated into the vector pET-28a(+). Then, recombinant expressing plasmids were induced by IPTG for p21Ras expression in E. coli. Hybridoma cell lines producing anti-p21Ras monoclonal antibodies were isolated using wildtype p21Ras proteins as immunogens. Anti-p21Ras scFv antibody was prepared from the hybridoma by the phage scFv display method. The immunoreactivity of the anti-p21Ras monoclonal antibody and the scFv antibody was identified by ELISA and immunocytochemistry.
Results: We prokaryotically expressed wildtype H-p21Ras, K-p21Ras and N-p21Ras and generated the hybridoma cell line KGH-R1, producing anti-p21Ras monoclonal antibodies. It was demonstrated that KGH-R1 monoclonal antibody could recognize wildtype and mutated H-p21Ras, K-p21Ras and N-p21Ras in human tumour cell lines. In all 14 types of primary human cancer tissues tested, the monoclonal antibody presented strong immunoreactivity but showed weak or negative immunoreactivity in the corresponding normal tissues. Subsequently, we prepared anti-p21Ras scFv from hybridoma KGH-R1, which showed the same immunoreactivity as the original monoclonal antibody. Sequence analysis demonstrated that the nucleotides and amino acids of the scFv exhibited an approximately 50 % difference from the anti-p21Ras scFv reported previously.
Conclusions: This study presents a novel anti-p21Ras scFv antibody. Our data suggest that the scFv may be useful for ras signalling blockage and may be a potential therapeutic antibody for ras-derived tumours.
推荐引用方式
GB/T 7714：

Yang Ju-Lun,Liu Du-Xian,Zhen Shi-Jian, et al. A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues [J].BMC CANCER,2016,16.
APA：

Yang Ju-Lun,Liu Du-Xian,Zhen Shi-Jian,Zhou Yun-Gang,&Feng Qiang.(2016).A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues .BMC CANCER,16.
MLA：

Yang Ju-Lun, et al. "A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues" .BMC CANCER 16(2016).
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：91  下载次数：0

分享到：

浏览次数：91

下载次数：0

打印次数：0